Low levels of herpes simplex virus thymidine-thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model
- 1 February 1989
- Vol. 168 (2) , 221-231
- https://doi.org/10.1016/0042-6822(89)90261-4
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- A Genetic Approach to Promoter Recognition During trans Induction of Viral Gene ExpressionScience, 1986
- The Complete DNA Sequence of Varicella-Zoster VirusJournal of General Virology, 1986
- Mutation within the herpes simplex virus DNA polymerase gene conferring resistance to (R)-9-(3,4-dihydroxybutyl)guanineAntimicrobial Agents and Chemotherapy, 1986
- Infections with Herpes Simplex VirusesNew England Journal of Medicine, 1986
- Mutations in the herpes simplex virus major DNA-binding protein gene leading to altered sensitivity to DNA polymerase inhibitorsVirology, 1985
- Metabolic fate of (E)-5-(2-bromovinyl)-2'-deoxyuridine in herpes simplex virus- and mock-infected cellsAntimicrobial Agents and Chemotherapy, 1984
- Activation by thymidine kinase and potent antiherpetic activity of 2′-nor-2′-deoxyguanosine (2′NDG)Biochemical and Biophysical Research Communications, 1982
- In vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl)-2'-deoxyuridine and related compoundsAntimicrobial Agents and Chemotherapy, 1982
- Isolation and Characterization of Acyclovir-resistant Mutants of Herpes Simplex VirusJournal of General Virology, 1980
- Comparative Efficacy of Antiherpes Drugs against Different Strains of Herpes Simplex VirusThe Journal of Infectious Diseases, 1980